Norovirus has no treatment and is highly contagious. It can linger on objects and surfaces for days or even weeks, as it’s resistant to most disinfectants and hand sanitizers, according to the ...

A “WORRYING” surge in cases of a winter virus causing violent vomiting and diarrhea is flooding NHS hospitals. Norovirus, ...

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

Shionogi’s respiratory syncytial virus (RSV) antiviral for adults has proven its ability to reduce viral load in a phase 2 ...

In the throes of winter's yearly round of respiratory virus outbreaks, it pays to remember what Grandma told you.

U.S. surges of COVID-19, influenza, respiratory syncytial virus (RSV) and norovirus have collectively been dubbed a ...

Among adults aged 75 and older, RSV was linked to a substantial burden of hospitalizations, ICU admissions, and in-hospital deaths before vaccines were available.

The study, published Jan. 20 in The Lancet Infectious Diseases, found the vaccine to be 78% effective against RSV infection, 79% effective against emergency department and urgent care visits and 80% ...

At the start of every week, our team talks with local experts to unpack a wide range of nationwide health, safety, and ...

The 30-day risks of hospitalization were 17.5%, 15.9%, and 14.4% for COVID, influenza, and RSV, respectively, during the 2022 ...